Dr. Erin Murphy Talks About Treatments For Young Ependymoma Patients
Dr. Erin Murphy talks about a study presented by Dr. Thomas E. Merchant regarding young patients with ependymoma and how they can be treated effectively with a regiment of adjuvant radiation.
Erin Murphy, MD, Radiation Oncologist at Cleveland Clinic, talks about a study presented by Thomas E. Merchant, DO, PhD, Chair, Radiation Oncology Department at St. Jude Children’s Research regarding young patients with ependymoma and how they can be treated effectively with a regiment of adjuvant radiation.
Murphy says that some patients who undergo a subtotal resection for ependymoma can go on to receive chemotherapy and possibly be eligible for a gross total resection.
Imlunestrant Improves PFS in ESR1-Mutant Advanced Breast Cancer
December 13th 2024The phase 3 EMBER-3 trial showed imlunestrant improved PFS over SOC endocrine therapy in ER-positive, HER2-negative advanced breast cancer with ESR1 mutations, though not significantly in the overall population.
Read More
ctDNA Detection Tied to Tumor Burden, Recurrence in HR+ Early Breast Cancer
December 13th 2024A phase 2 trial showed ctDNA detection in HR-positive early breast cancer was linked to larger tumors, higher residual cancer burden, and increased recurrence after neoadjuvant endocrine therapy.
Read More
Postoperative Radiation Improves HRQOL Over Endocrine Therapy in Breast Cancer
December 13th 2024In the phase 3 EUROPA trial, exclusive postoperative radiation therapy led to better health-related quality of life and fewer treatment-related adverse events in older patients with stage I luminal-like breast cancer at 24 months.
Read More
